Prolonged release oxycodone–naloxone for treatment of severe restless legs syndrome after failure of...
Prolonged release oxycodone–naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension
About this item
Full title
Author / Creator
Trenkwalder, Claudia, Prof , Beneš, Heike, MD , Grote, Ludger, MD , García-Borreguero, Diego, MD , Högl, Birgit, MD , Hopp, Michael, MD , Bosse, Björn, Dipl Stat , Oksche, Alexander, MD , Reimer, Karen, Prof , Winkelmann, Juliane, Prof , Allen, Richard P, PhD , Kohnen, Ralf, PhD , for the RELOXYN Study Group and RELOXYN Study Group
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Summary Background Opioids are a potential new treatment for severe restless legs syndrome. We investigated the efficacy and safety of a fixed-dose combination of prolonged release oxycodone–naloxone for patients with severe restless legs syndrome inadequately controlled by previous, mainly dopaminergic, treatment. Methods This multicentre study co...
Alternative Titles
Full title
Prolonged release oxycodone–naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension
Authors, Artists and Contributors
Author / Creator
Beneš, Heike, MD
Grote, Ludger, MD
García-Borreguero, Diego, MD
Högl, Birgit, MD
Hopp, Michael, MD
Bosse, Björn, Dipl Stat
Oksche, Alexander, MD
Reimer, Karen, Prof
Winkelmann, Juliane, Prof
Allen, Richard P, PhD
Kohnen, Ralf, PhD
for the RELOXYN Study Group
RELOXYN Study Group
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1492609952
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1492609952
Other Identifiers
ISSN
1474-4422
E-ISSN
1474-4465
DOI
10.1016/S1474-4422(13)70239-4
